Compare GERN & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GERN | CIFR |
|---|---|---|
| Founded | 1990 | 2021 |
| Country | United States | United States |
| Employees | 229 | 66 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 6.3B |
| IPO Year | N/A | N/A |
| Metric | GERN | CIFR |
|---|---|---|
| Price | $1.46 | $14.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | $2.17 | ★ $24.45 |
| AVG Volume (30 Days) | 16.5M | ★ 26.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $32.27 | $81.47 |
| Revenue Next Year | $60.16 | $152.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.04 | $1.86 |
| 52 Week High | $2.01 | $25.52 |
| Indicator | GERN | CIFR |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 43.65 |
| Support Level | $1.20 | $13.84 |
| Resistance Level | $1.68 | $15.54 |
| Average True Range (ATR) | 0.16 | 1.48 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 5.08 | 19.33 |
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
Cipher Digital Inc is focused on high-performance computing (HPC) data center development and operations. It is engaged in developing and operating data centers designed for HPC workloads. Its operations include managing power assets and capital allocation in response to market conditions and demand for AI-related computing capacity.